Metatron Health

Botanical species · safety record

Ipomoea nil

The EFSA Compendium of Botanicals holds 4 constituent measurements for Ipomoea nil. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ipomoea nil (L.) Roth

4Constituent measurements
0Safety records
4Cited sources
26Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 26 licensed products naming Ipomoea nil as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • New material
  • Seed
  • Seed(s)

What the records describe

Constituents measured

  • Ergoline alkaloids1
  • Lignans1
  • Putrescine1
  • Triterpene saponins1

Plant parts

  • Seed4

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Ergoline alkaloidsSeed——Chromatographic testsNo resolvable identifier
LignansSeedSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier
PutrescineSeedSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Triterpene saponinsSeedSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Abou-Chaar, Charles I. Alkaloids of an Ipomoea seed. Lebanese pharmaceutical journal, 1967, p. 93-109.
  2. Kim, Ki Hyun., Ha, Sang Keun., Choi, Sang Un., Kim, Sun Yeou., Lee, Kang Ro. Bioactive Phenolic Constituents from the Seeds of Pharbitis nil. Chemical & pharmaceutical bulletin, 2011, vol. 59, no. 11, p. 1425-1429.
  3. Jung, Da Young., Ha, Hyekyung., Lee, Ho Young., Kim, Chungsook., Lee, Je-Hyun., Bae, Kihwan., Kim, Ju Sun., Kang, Sam Sik. Triterpenoid saponins from the seeds of Pharbitis nil.. Chemical & pharmaceutical bulletin, 2008, vol. 56, no. 2, p. 203-6.
  4. Kim, Ki Hyun., Choi, Sang Un., Son, Mi Won., Lee, Kang Ro. Two New Phenolic Amides from the Seeds of Pharbitis nil. Chemical & pharmaceutical bulletin, 2010, vol. 58, no. 11, p. 1532-1535.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.